Piperidine-based glycodendrons as protein N-glycan prosthetics
Bioorganic & Medicinal Chemistry, ISSN: 0968-0896, Vol: 24, Issue: 20, Page: 4791-4800
2016
- 4Citations
- 27Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations4
- Citation Indexes4
- CrossRef4
- Captures27
- Readers27
- 27
Article Description
The generation of homogeneously glycosylated proteins is essential for defining glycoform-specific activity and improving protein-based therapeutics. We present a novel glycodendron prosthetic which can be site-selectively appended to recombinant proteins to create ‘ N -glycosylated’ glycoprotein mimics. Using computational modeling, we designed the dendrimer scaffold and protein attachment point to resemble the native N-glycan architecture. Three piperidine–melamine glycodendrimers were synthesized via a chemoenzymatic route and attached to human growth hormone and the F c region of human IgG. These products represent a new class of engineered biosimilars bearing novel glycodendrimer structures.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0968089616303832; http://dx.doi.org/10.1016/j.bmc.2016.05.050; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84988934077&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/27283789; https://linkinghub.elsevier.com/retrieve/pii/S0968089616303832
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know